What is HC Wainwright’s Estimate for IKT Q1 Earnings?
Inhibikase Therapeutics, Inc. (NYSE:IKT – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 EPS estimates for Inhibikase Therapeutics in a research report issued on Wednesday, February 12th. HC Wainwright analyst E. White expects that the company will post earnings of ($0.10) per share for the quarter. HC Wainwright currently has a […]
Inhibikase Therapeutics, Inc. (NYSE:IKT – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 EPS estimates for Inhibikase Therapeutics in a research report issued on Wednesday, February 12th. HC Wainwright analyst E. White expects that the company will post earnings of ($0.10) per share for the quarter. HC Wainwright currently has a […]
